Browse by author
Lookup NU author(s): Dr Stephany Veuger, Professor barbara Durkacz
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Recent reports implicate poly(ADP-ribose) polymerase-1 (PARP-1) in the activation of nuclear factor kappaB (NF-B). We investigated the role of PARP-1 in the NF-B signalling cascade induced by ionizing radiation (IR). AG14361, a potent PARP-1 inhibitor, was used in two breast cancer cell lines expressing different levels of constitutively activated NF-B, as well as mouse embryonic fibroblasts (MEFs) proficient or deficient for PARP-1 or NF-B p65. In the breast cancer cell lines, AG14361 had no effect on IR-induced degradation of IB or nuclear translocation of p50 or p65. However, AG14361 inhibited IR-induced NF-B-dependent transcription of a luciferase reporter gene. Similarly, in PARP-1-/- MEFs, IR-induced nuclear translocation of p50 and p65 was normal, but B binding and transcriptional activation did not occur. AG14361 sensitized both breast cancer cell lines to IR-induced cell killing, inhibited IR-induced XIAP expression and increased caspase-3 activity. However, AG14361 failed to increase IR-induced caspase activity when p65 was knocked down by siRNA. Consistent with this, AG14361 sensitized p65+/+ but not p65-/- MEFs to IR. We conclude that PARP-1 activity is essential in the upstream regulation of IR-induced NF-B activation. These data indicate that potentiation of IR-induced cytotoxicity by AG14361 is mediated solely by inhibition of NF-B activation.
Author(s): Veuger SJ, Hunter JE, Durkacz BW
Publication type: Article
Publication status: Published
Journal: Oncogene
Year: 2009
Volume: 28
Issue: 6
Pages: 832-842
ISSN (print): 0950-9232
Publisher: Nature Publishing Group
URL: http://dx.doi.org/10.1038/onc.2008.439
DOI: 10.1038/onc.2008.439
Altmetrics provided by Altmetric
